Onconic Therapeutics Inc. (KOSDAQ:476060)
South Korea · Delayed Price · Currency is KRW 21,150
-44,050 (-67.56%)
Oct 10, 2025, 3:30 PM KST
Onconic Therapeutics Market Cap
Onconic Therapeutics has a market cap or net worth of 940.05 billion as of October 10, 2025.
Market Cap
940.05B
Enterprise Value
895.09B
Revenue
29.43B
Ranking
n/a
PE Ratio
63.44
Stock Price
21,150.00
Market Cap Chart
Since December 19, 2024, Onconic Therapeutics's market cap has increased from 186.91B to 940.05B, an increase of 402.95%. That is a compound annual growth rate of 637.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 940.05B | 432.50% |
| Dec 30, 2024 | 176.54B | -5.55% |
| Dec 19, 2024 | 186.91B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.81T |
| Celltrion | 38.64T |
| ALTEOGEN | 25.22T |
| Yuhan | 8,969.60B |
| SK Biopharmaceuticals | 8,144.58B |
| Peptron | 7,006.86B |
| PharmaResearch | 5,714.31B |
| LigaChem Biosciences | 5,545.53B |